Andrew Bradford
Concepts (388)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| E2F1 Transcription Factor | 12 | 2026 | 68 | 1.870 |
Why?
| | Endometrial Neoplasms | 7 | 2021 | 197 | 1.680 |
Why?
| | Follicle Stimulating Hormone | 13 | 2023 | 243 | 1.590 |
Why?
| | Luteinizing Hormone | 13 | 2022 | 183 | 1.440 |
Why?
| | Prolactin | 10 | 2022 | 96 | 1.040 |
Why?
| | Hyperlipidemias | 3 | 2022 | 125 | 0.990 |
Why?
| | Hyperinsulinism | 3 | 2022 | 122 | 0.970 |
Why?
| | Obesity | 16 | 2024 | 3008 | 0.960 |
Why?
| | Leiomyoma | 3 | 2019 | 56 | 0.960 |
Why?
| | Promoter Regions, Genetic | 18 | 2025 | 1243 | 0.950 |
Why?
| | Uterine Neoplasms | 3 | 2019 | 92 | 0.930 |
Why?
| | Protein Kinase C-alpha | 3 | 2009 | 37 | 0.870 |
Why?
| | Gene Expression Regulation, Neoplastic | 12 | 2026 | 1435 | 0.850 |
Why?
| | Metabolic Syndrome | 4 | 2024 | 349 | 0.800 |
Why?
| | Pituitary Gland | 7 | 2021 | 150 | 0.800 |
Why?
| | Human Growth Hormone | 1 | 2022 | 48 | 0.720 |
Why?
| | Proto-Oncogene Proteins | 9 | 2015 | 624 | 0.720 |
Why?
| | Gene Expression Profiling | 6 | 2019 | 1771 | 0.700 |
Why?
| | Corpus Luteum | 3 | 2016 | 20 | 0.700 |
Why?
| | Soybean Oil | 1 | 2021 | 15 | 0.700 |
Why?
| | Protein Kinase C-delta | 5 | 2009 | 48 | 0.690 |
Why?
| | Gene Products, tax | 3 | 2025 | 15 | 0.680 |
Why?
| | Human T-lymphotropic virus 1 | 3 | 2025 | 32 | 0.670 |
Why?
| | Phospholipids | 2 | 2021 | 221 | 0.640 |
Why?
| | Cell Proliferation | 10 | 2026 | 2506 | 0.620 |
Why?
| | Leiomyosarcoma | 1 | 2019 | 29 | 0.610 |
Why?
| | E2F Transcription Factors | 5 | 2025 | 62 | 0.580 |
Why?
| | Apoptosis | 12 | 2026 | 2575 | 0.540 |
Why?
| | Insulin | 5 | 2022 | 2491 | 0.510 |
Why?
| | Fibroblast Growth Factors | 4 | 2021 | 185 | 0.510 |
Why?
| | Transcriptional Activation | 5 | 2025 | 378 | 0.500 |
Why?
| | Gene Expression Regulation | 11 | 2023 | 2608 | 0.490 |
Why?
| | Diet, High-Fat | 3 | 2024 | 253 | 0.490 |
Why?
| | Signal Transduction | 12 | 2025 | 5168 | 0.480 |
Why?
| | High Fructose Corn Syrup | 1 | 2015 | 8 | 0.470 |
Why?
| | Genes, Tumor Suppressor | 5 | 2026 | 84 | 0.470 |
Why?
| | Granulosa Cells | 1 | 2015 | 33 | 0.470 |
Why?
| | Weight Gain | 2 | 2016 | 539 | 0.450 |
Why?
| | Proto-Oncogene Proteins c-ets | 8 | 2007 | 56 | 0.440 |
Why?
| | DEAD-box RNA Helicases | 2 | 2025 | 86 | 0.430 |
Why?
| | Fibroblast Growth Factor 2 | 3 | 2006 | 87 | 0.420 |
Why?
| | Cell Line, Tumor | 14 | 2026 | 3495 | 0.420 |
Why?
| | Dietary Fats | 1 | 2015 | 300 | 0.410 |
Why?
| | Adenocarcinoma | 3 | 2009 | 896 | 0.390 |
Why?
| | Transcription Factors | 8 | 2018 | 1712 | 0.380 |
Why?
| | MAP Kinase Signaling System | 3 | 2006 | 326 | 0.380 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1258 | 0.370 |
Why?
| | DNA-Binding Proteins | 8 | 2018 | 1485 | 0.370 |
Why?
| | MicroRNAs | 2 | 2015 | 692 | 0.350 |
Why?
| | Gonadotropins | 3 | 2023 | 40 | 0.350 |
Why?
| | Protein Kinase C | 2 | 2003 | 252 | 0.340 |
Why?
| | Aromatase Inhibitors | 3 | 2020 | 58 | 0.340 |
Why?
| | Cross-Over Studies | 3 | 2022 | 582 | 0.340 |
Why?
| | Fibroblast Growth Factor 4 | 3 | 2006 | 19 | 0.330 |
Why?
| | Homeodomain Proteins | 5 | 2012 | 515 | 0.320 |
Why?
| | Retinoblastoma Protein | 3 | 2026 | 59 | 0.320 |
Why?
| | Estradiol | 5 | 2023 | 528 | 0.310 |
Why?
| | Tumor Protein p73 | 2 | 2026 | 18 | 0.300 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 159 | 0.300 |
Why?
| | Female | 36 | 2024 | 75943 | 0.290 |
Why?
| | RNA, Messenger | 2 | 2015 | 2828 | 0.270 |
Why?
| | Hydrocortisone | 2 | 2022 | 318 | 0.270 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2024 | 529 | 0.270 |
Why?
| | Humans | 50 | 2026 | 141749 | 0.270 |
Why?
| | Menstrual Cycle | 2 | 2019 | 134 | 0.250 |
Why?
| | Growth Hormone | 3 | 2022 | 102 | 0.240 |
Why?
| | Ovarian Neoplasms | 1 | 2012 | 581 | 0.240 |
Why?
| | Neoplasms | 4 | 2026 | 2747 | 0.240 |
Why?
| | Leukemia-Lymphoma, Adult T-Cell | 1 | 2025 | 17 | 0.240 |
Why?
| | HTLV-I Infections | 1 | 2025 | 28 | 0.240 |
Why?
| | Isoenzymes | 3 | 2003 | 302 | 0.240 |
Why?
| | Cytokines | 4 | 2024 | 2099 | 0.230 |
Why?
| | Weight Loss | 2 | 2024 | 791 | 0.220 |
Why?
| | Cell Cycle Proteins | 4 | 2023 | 632 | 0.220 |
Why?
| | Protein-Arginine N-Methyltransferases | 1 | 2024 | 25 | 0.210 |
Why?
| | Adipokines | 1 | 2024 | 52 | 0.210 |
Why?
| | Tumor Cells, Cultured | 5 | 2007 | 962 | 0.210 |
Why?
| | Live Birth | 1 | 2024 | 68 | 0.210 |
Why?
| | Phosphorylation | 5 | 2024 | 1774 | 0.210 |
Why?
| | Preconception Care | 1 | 2024 | 48 | 0.200 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2024 | 131 | 0.200 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2016 | 122 | 0.200 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2003 | 59 | 0.200 |
Why?
| | Persian Gulf Syndrome | 1 | 2023 | 18 | 0.200 |
Why?
| | Transcription Factor DP1 | 2 | 2023 | 21 | 0.200 |
Why?
| | Irritable Bowel Syndrome | 1 | 2023 | 29 | 0.190 |
Why?
| | Gonadotropin-Releasing Hormone | 4 | 2021 | 213 | 0.190 |
Why?
| | Fertility | 1 | 2024 | 165 | 0.190 |
Why?
| | Pituitary Hormones | 1 | 2022 | 16 | 0.190 |
Why?
| | Animals | 20 | 2025 | 37748 | 0.190 |
Why?
| | Rats | 10 | 2006 | 5637 | 0.180 |
Why?
| | Transcription Factor Pit-1 | 6 | 2003 | 27 | 0.180 |
Why?
| | Thyroid Hormones | 1 | 2022 | 68 | 0.180 |
Why?
| | Thyrotropin | 1 | 2022 | 117 | 0.180 |
Why?
| | Hypothalamus | 2 | 2014 | 155 | 0.180 |
Why?
| | Transcription, Genetic | 3 | 2009 | 1487 | 0.180 |
Why?
| | Mindfulness | 1 | 2024 | 148 | 0.180 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 3 | 1997 | 263 | 0.180 |
Why?
| | Emulsions | 1 | 2021 | 55 | 0.170 |
Why?
| | Gastrointestinal Diseases | 1 | 2023 | 207 | 0.170 |
Why?
| | Tandem Mass Spectrometry | 2 | 2015 | 568 | 0.170 |
Why?
| | Thinness | 1 | 2021 | 96 | 0.170 |
Why?
| | Heparin | 1 | 2022 | 259 | 0.170 |
Why?
| | Leptin | 1 | 2022 | 242 | 0.170 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2021 | 158 | 0.160 |
Why?
| | Gastroesophageal Reflux | 1 | 2023 | 244 | 0.160 |
Why?
| | Wnt Proteins | 1 | 2021 | 136 | 0.160 |
Why?
| | Adiponectin | 1 | 2022 | 244 | 0.160 |
Why?
| | Creatinine | 1 | 2022 | 490 | 0.160 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p18 | 2 | 2016 | 15 | 0.160 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 2 | 2012 | 175 | 0.160 |
Why?
| | Enzyme Activation | 3 | 2009 | 811 | 0.160 |
Why?
| | Proto-Oncogene Protein c-ets-1 | 6 | 2003 | 25 | 0.160 |
Why?
| | Bcl-2-Like Protein 11 | 2 | 2016 | 38 | 0.160 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 325 | 0.160 |
Why?
| | Feasibility Studies | 1 | 2024 | 1027 | 0.160 |
Why?
| | Lipids | 2 | 2022 | 690 | 0.160 |
Why?
| | Chitinase-3-Like Protein 1 | 1 | 2019 | 19 | 0.160 |
Why?
| | Adult | 17 | 2024 | 39391 | 0.150 |
Why?
| | Cell Cycle | 2 | 2015 | 600 | 0.150 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2019 | 70 | 0.150 |
Why?
| | Wnt Signaling Pathway | 1 | 2021 | 202 | 0.150 |
Why?
| | Biomarkers | 2 | 2024 | 4190 | 0.150 |
Why?
| | beta Catenin | 1 | 2021 | 258 | 0.150 |
Why?
| | Eicosapentaenoic Acid | 1 | 2019 | 38 | 0.150 |
Why?
| | Cytoskeletal Proteins | 1 | 2019 | 156 | 0.150 |
Why?
| | Follicular Phase | 2 | 2015 | 39 | 0.140 |
Why?
| | Docosahexaenoic Acids | 1 | 2019 | 86 | 0.140 |
Why?
| | Gene Knockdown Techniques | 2 | 2009 | 333 | 0.140 |
Why?
| | Microtubule-Associated Proteins | 1 | 2019 | 198 | 0.140 |
Why?
| | Estrone | 2 | 2015 | 36 | 0.140 |
Why?
| | Immunoenzyme Techniques | 2 | 2009 | 209 | 0.140 |
Why?
| | Estrogens | 3 | 2019 | 368 | 0.140 |
Why?
| | Pituitary Gland, Anterior | 1 | 1997 | 38 | 0.140 |
Why?
| | Etoposide | 2 | 2009 | 164 | 0.140 |
Why?
| | Genes, p16 | 1 | 2016 | 15 | 0.130 |
Why?
| | Pregnancy | 4 | 2024 | 7092 | 0.130 |
Why?
| | Aromatase | 2 | 2014 | 32 | 0.130 |
Why?
| | Fibroblasts | 3 | 2018 | 1020 | 0.130 |
Why?
| | Oncogene Proteins | 1 | 1996 | 63 | 0.120 |
Why?
| | Genes, ras | 2 | 1997 | 95 | 0.120 |
Why?
| | Mice, Nude | 2 | 2025 | 691 | 0.120 |
Why?
| | Blotting, Western | 2 | 2009 | 1234 | 0.120 |
Why?
| | Stress, Psychological | 1 | 2024 | 1133 | 0.120 |
Why?
| | Ovulation | 1 | 2015 | 40 | 0.120 |
Why?
| | Molecular Sequence Annotation | 1 | 2015 | 95 | 0.120 |
Why?
| | Cumulus Cells | 1 | 2015 | 6 | 0.110 |
Why?
| | Young Adult | 10 | 2024 | 13749 | 0.110 |
Why?
| | RNA-Binding Proteins | 1 | 2019 | 447 | 0.110 |
Why?
| | Dietary Supplements | 2 | 2019 | 570 | 0.110 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1502 | 0.110 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2023 | 861 | 0.110 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2016 | 368 | 0.110 |
Why?
| | Tumor Suppressor Protein p14ARF | 1 | 2014 | 7 | 0.110 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2015 | 194 | 0.110 |
Why?
| | Transcription Factors, TFII | 2 | 2024 | 44 | 0.110 |
Why?
| | Sensitivity and Specificity | 1 | 2019 | 1977 | 0.110 |
Why?
| | Blood Chemical Analysis | 1 | 2015 | 110 | 0.110 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2015 | 142 | 0.110 |
Why?
| | Hormone Antagonists | 1 | 2014 | 34 | 0.110 |
Why?
| | Luteal Phase | 1 | 2014 | 46 | 0.110 |
Why?
| | Hypogonadism | 3 | 2024 | 92 | 0.100 |
Why?
| | Transfection | 3 | 2009 | 943 | 0.100 |
Why?
| | Repressor Proteins | 1 | 1997 | 430 | 0.100 |
Why?
| | Neoplasms, Experimental | 1 | 2014 | 174 | 0.100 |
Why?
| | RNA Interference | 2 | 2018 | 469 | 0.100 |
Why?
| | Circadian Rhythm | 1 | 2017 | 515 | 0.100 |
Why?
| | Postmenopause | 1 | 2015 | 371 | 0.100 |
Why?
| | Culture Media, Serum-Free | 2 | 2003 | 46 | 0.100 |
Why?
| | Base Sequence | 3 | 2012 | 2180 | 0.090 |
Why?
| | DNA Fingerprinting | 1 | 2012 | 29 | 0.090 |
Why?
| | Exercise | 1 | 2024 | 2112 | 0.090 |
Why?
| | RNA, Small Interfering | 2 | 2018 | 627 | 0.090 |
Why?
| | Breast Neoplasms | 3 | 2012 | 2257 | 0.090 |
Why?
| | Cell Line | 5 | 2018 | 2887 | 0.090 |
Why?
| | DNA, Complementary | 2 | 2012 | 274 | 0.090 |
Why?
| | Tumor Suppressor Proteins | 1 | 2014 | 326 | 0.090 |
Why?
| | Testosterone | 1 | 2015 | 405 | 0.090 |
Why?
| | Pulsatile Flow | 1 | 2011 | 55 | 0.090 |
Why?
| | Veterans | 1 | 2023 | 1525 | 0.090 |
Why?
| | NF-kappa B | 2 | 2025 | 692 | 0.080 |
Why?
| | Protein Isoforms | 2 | 2003 | 398 | 0.080 |
Why?
| | Cell Survival | 2 | 2021 | 1134 | 0.080 |
Why?
| | Pituitary Neoplasms | 2 | 2003 | 197 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 987 | 0.080 |
Why?
| | Adiposity | 1 | 2015 | 521 | 0.080 |
Why?
| | Mutation | 1 | 2021 | 4015 | 0.080 |
Why?
| | Colony-Forming Units Assay | 1 | 2009 | 96 | 0.080 |
Why?
| | Infertility, Female | 2 | 2024 | 108 | 0.080 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 74 | 0.080 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2009 | 73 | 0.080 |
Why?
| | Luciferases | 1 | 2009 | 150 | 0.080 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2009 | 82 | 0.080 |
Why?
| | Transforming Growth Factor beta | 1 | 2012 | 497 | 0.080 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2015 | 761 | 0.080 |
Why?
| | Progesterone | 3 | 2016 | 263 | 0.080 |
Why?
| | Cyclin D1 | 1 | 2009 | 68 | 0.080 |
Why?
| | Models, Biological | 2 | 2016 | 1828 | 0.070 |
Why?
| | Inflammation | 2 | 2024 | 2902 | 0.070 |
Why?
| | Mutant Proteins | 1 | 2009 | 102 | 0.070 |
Why?
| | NIH 3T3 Cells | 1 | 2009 | 149 | 0.070 |
Why?
| | Membrane Proteins | 1 | 2015 | 1158 | 0.070 |
Why?
| | Matrix Metalloproteinase 11 | 1 | 2008 | 4 | 0.070 |
Why?
| | Mice | 5 | 2025 | 18108 | 0.070 |
Why?
| | PTEN Phosphohydrolase | 1 | 2009 | 163 | 0.070 |
Why?
| | RNA, Neoplasm | 1 | 2008 | 79 | 0.070 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2012 | 547 | 0.070 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 281 | 0.070 |
Why?
| | Myometrium | 1 | 2008 | 39 | 0.070 |
Why?
| | Neoplastic Stem Cells | 1 | 2012 | 408 | 0.070 |
Why?
| | DNA, Neoplasm | 1 | 2008 | 158 | 0.070 |
Why?
| | Rabbits | 1 | 2009 | 754 | 0.070 |
Why?
| | Cell Adhesion | 1 | 2009 | 469 | 0.070 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2024 | 1634 | 0.070 |
Why?
| | Neoplasm Invasiveness | 1 | 2009 | 510 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2009 | 444 | 0.070 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2007 | 122 | 0.070 |
Why?
| | DNA Primers | 1 | 2008 | 510 | 0.070 |
Why?
| | Subcellular Fractions | 1 | 2006 | 78 | 0.060 |
Why?
| | Proto-Oncogene Proteins c-raf | 2 | 1997 | 44 | 0.060 |
Why?
| | HeLa Cells | 2 | 2000 | 640 | 0.060 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2016 | 74 | 0.060 |
Why?
| | Mammary Glands, Human | 1 | 2007 | 66 | 0.060 |
Why?
| | Immunoprecipitation | 1 | 2006 | 154 | 0.060 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2006 | 100 | 0.060 |
Why?
| | DNA Damage | 1 | 2009 | 429 | 0.060 |
Why?
| | Growth Hormone-Releasing Hormone | 1 | 2006 | 25 | 0.060 |
Why?
| | raf Kinases | 1 | 2006 | 12 | 0.060 |
Why?
| | Ultraviolet Rays | 1 | 2009 | 401 | 0.060 |
Why?
| | Autocrine Communication | 1 | 2006 | 40 | 0.060 |
Why?
| | Receptors, Growth Factor | 1 | 2006 | 56 | 0.060 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1997 | 174 | 0.060 |
Why?
| | Prostate | 1 | 2007 | 173 | 0.060 |
Why?
| | Paracrine Communication | 1 | 2006 | 66 | 0.060 |
Why?
| | Protein Kinase Inhibitors | 2 | 2009 | 919 | 0.060 |
Why?
| | Caspases | 1 | 2006 | 245 | 0.060 |
Why?
| | Middle Aged | 3 | 2024 | 34647 | 0.060 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2006 | 192 | 0.060 |
Why?
| | Reproduction | 1 | 2007 | 206 | 0.060 |
Why?
| | ras Proteins | 1 | 2006 | 148 | 0.060 |
Why?
| | Protein Binding | 2 | 2024 | 2242 | 0.060 |
Why?
| | Hypothalamo-Hypophyseal System | 2 | 2017 | 207 | 0.060 |
Why?
| | Prospective Studies | 4 | 2023 | 7777 | 0.060 |
Why?
| | Adolescent | 7 | 2021 | 22130 | 0.060 |
Why?
| | Oncogene Protein p65(gag-jun) | 1 | 2004 | 2 | 0.060 |
Why?
| | Pituitary Hormones, Anterior | 1 | 2024 | 7 | 0.050 |
Why?
| | Ideal Body Weight | 1 | 2024 | 4 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2006 | 317 | 0.050 |
Why?
| | Cyclin D2 | 1 | 2024 | 5 | 0.050 |
Why?
| | Cell Movement | 1 | 2009 | 990 | 0.050 |
Why?
| | Ovulation Induction | 2 | 2015 | 58 | 0.050 |
Why?
| | Cell Nucleus | 1 | 2007 | 609 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2004 | 57 | 0.050 |
Why?
| | Cyclin-Dependent Kinase 2 | 1 | 2024 | 40 | 0.050 |
Why?
| | Jurkat Cells | 1 | 2024 | 138 | 0.050 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2024 | 80 | 0.050 |
Why?
| | Body Mass Index | 3 | 2021 | 2385 | 0.050 |
Why?
| | Diet, Fat-Restricted | 1 | 2024 | 78 | 0.050 |
Why?
| | Pregnancy Rate | 1 | 2024 | 67 | 0.050 |
Why?
| | Thiocarbamates | 1 | 2003 | 6 | 0.050 |
Why?
| | Phospholipid Ethers | 1 | 2003 | 7 | 0.050 |
Why?
| | Gene Expression | 2 | 2021 | 1492 | 0.050 |
Why?
| | Thiones | 1 | 2003 | 14 | 0.050 |
Why?
| | Norbornanes | 1 | 2003 | 14 | 0.050 |
Why?
| | Chromones | 1 | 2003 | 44 | 0.050 |
Why?
| | Bridged-Ring Compounds | 1 | 2003 | 27 | 0.050 |
Why?
| | E2F3 Transcription Factor | 1 | 2023 | 10 | 0.050 |
Why?
| | Follicle Stimulating Hormone, Human | 1 | 2023 | 12 | 0.050 |
Why?
| | Culturally Competent Care | 1 | 2024 | 68 | 0.050 |
Why?
| | Gulf War | 1 | 2023 | 15 | 0.050 |
Why?
| | Immunohistochemistry | 1 | 2007 | 1739 | 0.050 |
Why?
| | Androstadienes | 1 | 2003 | 78 | 0.050 |
Why?
| | Abortion, Spontaneous | 1 | 2024 | 116 | 0.050 |
Why?
| | Cell Death | 1 | 2024 | 387 | 0.050 |
Why?
| | Thyroid Neoplasms | 1 | 2007 | 327 | 0.050 |
Why?
| | Protein Domains | 1 | 2024 | 304 | 0.050 |
Why?
| | Morpholines | 1 | 2003 | 127 | 0.050 |
Why?
| | Molecular Sequence Data | 4 | 2012 | 2929 | 0.050 |
Why?
| | Cluster Analysis | 2 | 2015 | 521 | 0.050 |
Why?
| | Acetophenones | 1 | 2001 | 14 | 0.050 |
Why?
| | Models, Molecular | 1 | 2007 | 1604 | 0.040 |
Why?
| | Benzopyrans | 1 | 2001 | 30 | 0.040 |
Why?
| | Carbazoles | 1 | 2001 | 56 | 0.040 |
Why?
| | Heterocyclic Compounds, 3-Ring | 1 | 2021 | 37 | 0.040 |
Why?
| | Naphthalenes | 1 | 2001 | 59 | 0.040 |
Why?
| | Transcription Factor CHOP | 1 | 2021 | 33 | 0.040 |
Why?
| | Fat Emulsions, Intravenous | 1 | 2021 | 29 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2024 | 519 | 0.040 |
Why?
| | Focus Groups | 1 | 2024 | 572 | 0.040 |
Why?
| | Immunoblotting | 1 | 2001 | 310 | 0.040 |
Why?
| | Indazoles | 1 | 2021 | 74 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2004 | 377 | 0.040 |
Why?
| | Adenoviridae | 1 | 2001 | 201 | 0.040 |
Why?
| | Genetic Fitness | 1 | 2021 | 57 | 0.040 |
Why?
| | Self Efficacy | 1 | 2024 | 408 | 0.040 |
Why?
| | Glucose Clamp Technique | 1 | 2021 | 197 | 0.040 |
Why?
| | Heat-Shock Proteins | 1 | 2021 | 142 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2021 | 118 | 0.040 |
Why?
| | Imidazoles | 1 | 2021 | 255 | 0.040 |
Why?
| | Aged | 1 | 2019 | 24746 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2024 | 663 | 0.040 |
Why?
| | DNA | 2 | 1997 | 1444 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2021 | 353 | 0.040 |
Why?
| | Histones | 1 | 2024 | 639 | 0.040 |
Why?
| | Pancreatic Neoplasms | 1 | 2007 | 890 | 0.040 |
Why?
| | ADP-Ribosylation Factors | 1 | 2018 | 18 | 0.040 |
Why?
| | Progestins | 1 | 2019 | 81 | 0.040 |
Why?
| | Self Report | 1 | 2023 | 861 | 0.040 |
Why?
| | Feeding Behavior | 1 | 2024 | 682 | 0.040 |
Why?
| | Cell Differentiation | 1 | 2006 | 2006 | 0.040 |
Why?
| | Molecular Targeted Therapy | 1 | 2021 | 420 | 0.030 |
Why?
| | Dimerization | 1 | 2018 | 196 | 0.030 |
Why?
| | Academic Medical Centers | 1 | 2021 | 531 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 2001 | 855 | 0.030 |
Why?
| | Recurrence | 1 | 2021 | 1111 | 0.030 |
Why?
| | Indoles | 1 | 2001 | 478 | 0.030 |
Why?
| | Proto-Oncogene Protein c-ets-2 | 1 | 1997 | 4 | 0.030 |
Why?
| | Ectopic Gene Expression | 1 | 2016 | 5 | 0.030 |
Why?
| | Pyridines | 1 | 2021 | 557 | 0.030 |
Why?
| | Disease Management | 1 | 2021 | 633 | 0.030 |
Why?
| | ets-Domain Protein Elk-1 | 1 | 1996 | 12 | 0.030 |
Why?
| | Catalysis | 1 | 1997 | 320 | 0.030 |
Why?
| | Pituitary-Adrenal System | 1 | 2017 | 172 | 0.030 |
Why?
| | Transduction, Genetic | 1 | 1996 | 136 | 0.030 |
Why?
| | Hormones | 1 | 2016 | 140 | 0.030 |
Why?
| | Administration, Cutaneous | 1 | 2015 | 129 | 0.030 |
Why?
| | Oocyte Retrieval | 1 | 2015 | 12 | 0.030 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2015 | 67 | 0.030 |
Why?
| | Neovascularization, Physiologic | 1 | 2016 | 182 | 0.030 |
Why?
| | Limit of Detection | 1 | 2015 | 94 | 0.030 |
Why?
| | Genes, Transgenic, Suicide | 1 | 2014 | 7 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2015 | 266 | 0.030 |
Why?
| | Protein-Tyrosine Kinases | 1 | 1997 | 431 | 0.030 |
Why?
| | Trans-Activators | 1 | 1997 | 394 | 0.030 |
Why?
| | Binding Sites | 1 | 1997 | 1316 | 0.030 |
Why?
| | Cellular Microenvironment | 1 | 2015 | 91 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 1997 | 674 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 346 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 1995 | 504 | 0.030 |
Why?
| | Ovary | 1 | 2015 | 225 | 0.030 |
Why?
| | Anions | 1 | 2013 | 32 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2015 | 386 | 0.030 |
Why?
| | Molecular Conformation | 1 | 2013 | 147 | 0.020 |
Why?
| | Chromatography, Liquid | 1 | 2015 | 453 | 0.020 |
Why?
| | Fatty Acids | 1 | 2015 | 450 | 0.020 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2012 | 156 | 0.020 |
Why?
| | Genetic Therapy | 1 | 2014 | 315 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 2024 | 2096 | 0.020 |
Why?
| | Heterografts | 1 | 2012 | 134 | 0.020 |
Why?
| | Gene Library | 1 | 2012 | 120 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2015 | 1250 | 0.020 |
Why?
| | Protein Kinases | 1 | 1992 | 308 | 0.020 |
Why?
| | Nitriles | 1 | 2011 | 188 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2015 | 876 | 0.020 |
Why?
| | Triazoles | 1 | 2011 | 162 | 0.020 |
Why?
| | Male | 4 | 2017 | 70179 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2024 | 11181 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2011 | 771 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2012 | 825 | 0.020 |
Why?
| | Receptors, Pituitary Hormone-Regulating Hormone | 1 | 2006 | 8 | 0.020 |
Why?
| | Receptors, Neuropeptide | 1 | 2006 | 12 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2017 | 5697 | 0.020 |
Why?
| | Transcriptome | 1 | 2012 | 1013 | 0.010 |
Why?
| | Liver | 1 | 1992 | 1820 | 0.010 |
Why?
| | Prognosis | 1 | 2012 | 4080 | 0.010 |
Why?
| | Suppression, Genetic | 1 | 2003 | 24 | 0.010 |
Why?
| | Genes, Dominant | 1 | 2003 | 97 | 0.010 |
Why?
| | Genetic Vectors | 1 | 2004 | 336 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2012 | 4421 | 0.010 |
Why?
| | Amino Acid Sequence | 2 | 1997 | 2158 | 0.010 |
Why?
| | Phosphothreonine | 1 | 1997 | 6 | 0.010 |
Why?
| | Sequence Alignment | 1 | 1997 | 363 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1997 | 391 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 1997 | 579 | 0.010 |
Why?
| | Drosophila Proteins | 1 | 1997 | 206 | 0.010 |
Why?
| | Nerve Tissue Proteins | 1 | 1997 | 605 | 0.010 |
Why?
| | Biological Evolution | 1 | 1997 | 493 | 0.010 |
Why?
| | Chromatography, Ion Exchange | 1 | 1992 | 53 | 0.010 |
Why?
| | Chromatography, Gel | 1 | 1992 | 131 | 0.010 |
Why?
| | Rats, Inbred Strains | 1 | 1992 | 345 | 0.010 |
Why?
| | Molecular Weight | 1 | 1992 | 329 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 336 | 0.010 |
Why?
| | Cytosol | 1 | 1992 | 230 | 0.010 |
Why?
| | Substrate Specificity | 1 | 1992 | 385 | 0.010 |
Why?
| | Peptides | 1 | 1997 | 979 | 0.010 |
Why?
| | Oligopeptides | 1 | 1992 | 275 | 0.010 |
Why?
| | Cells, Cultured | 1 | 1997 | 4209 | 0.000 |
Why?
| | Kinetics | 1 | 1992 | 1655 | 0.000 |
Why?
|
|
Bradford's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|